Indraprastha MedicalLimited Financials
| INDRAMEDCO | 380.40 15.20 3.84% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1.9 B | 1.8 B |
|
|
Indraprastha | Select Account or Indicator |
Understanding current and past Indraprastha MedicalLimited Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Indraprastha MedicalLimited's financial statements are interrelated, with each one affecting the others. For example, an increase in Indraprastha MedicalLimited's assets may result in an increase in income on the income statement.
Please note, the presentation of Indraprastha MedicalLimited's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Indraprastha MedicalLimited's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Indraprastha MedicalLimited's management manipulating its earnings.
Indraprastha MedicalLimited Stock Summary
Indraprastha MedicalLimited competes with Kamat Hotels, Steelcast, Taj GVK, Electrosteel Castings, and Vibhor Steel. Indraprastha MedicalLimited is entity of India. It is traded as Stock on NSE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE681B01017 |
| Business Address | Sarita Vihar, New |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.apollohospitals.com/delhi/ |
| Phone | 91 11 2692 5858 |
You should never invest in Indraprastha MedicalLimited without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Indraprastha Stock, because this is throwing your money away. Analyzing the key information contained in Indraprastha MedicalLimited's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Indraprastha MedicalLimited Key Financial Ratios
There are many critical financial ratios that Indraprastha MedicalLimited's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Indraprastha MedicalLimited reports annually and quarterly.| Revenue | 12.45 B | ||||
| Gross Profit | 7.74 B | ||||
| EBITDA | 2.1 B | ||||
| Net Income | 1.24 B | ||||
| Total Asset | 7.23 B |
Indraprastha MedicalLimited Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 4.3B | 4.6B | 5.6B | 7.2B | 8.3B | 4.7B | |
| Other Current Liab | 768.0M | 467.6M | 635M | 770.1M | 693.1M | 628.9M | |
| Net Debt | (171.0M) | (364.3M) | (497.8M) | (276.5M) | (248.9M) | (236.4M) | |
| Cash | 249.2M | 417.4M | 522.6M | 616M | 708.4M | 743.8M | |
| Net Receivables | 748.4M | 481.3M | 746.2M | 590.1M | 678.6M | 804.2M | |
| Inventory | 87.4M | 99.9M | 84.5M | 75.3M | 67.8M | 79.8M | |
| Other Current Assets | 303.2M | 333M | 138M | 153.1M | 137.8M | 130.9M | |
| Total Liab | 1.6B | 1.4B | 1.8B | 2.5B | 2.8B | 2.3B | |
| Total Current Assets | 1.4B | 1.6B | 2.2B | 3.1B | 3.5B | 3.7B | |
| Short Term Debt | 25.1M | (40.4M) | (44.6M) | 16.8M | 15.1M | 14.4M | |
| Accounts Payable | 366M | 370.4M | 522.9M | 773.5M | 889.5M | 501.3M | |
| Intangible Assets | 33.8M | 17.1M | 9.6M | 10.5M | 12.1M | 16.3M | |
| Retained Earnings | 1.4B | 2.0B | 2.6B | 3.6B | 4.1B | 4.3B | |
| Other Liab | 392.4M | 337.7M | 379.9M | 402.9M | 362.6M | 322.9M | |
| Net Tangible Assets | 2.4B | 2.7B | 2.7B | 3.2B | 3.7B | 2.6B | |
| Other Assets | 38.6M | 44.1M | 70.6M | 1.0 | 0.9 | 0.86 | |
| Net Invested Capital | 2.7B | 3.3B | 3.8B | 4.8B | 5.5B | 3.6B | |
| Net Working Capital | 255.2M | 639.3M | 934.5M | 1.4B | 1.6B | 1.7B |
Indraprastha MedicalLimited Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 40K | 100K | 42.8M | 40.6M | 36.5M | 35.6M | |
| Total Revenue | 6.0B | 8.6B | 11.0B | 12.4B | 14.3B | 7.2B | |
| Gross Profit | 3.5B | 4.8B | 6.2B | 4.5B | 5.2B | 4.0B | |
| Operating Income | 76.6M | 851.3M | 1.1B | 1.6B | 1.8B | 1.9B | |
| Ebit | 76.3M | 824.8M | 1.2B | 1.7B | 2.0B | 2.1B | |
| Ebitda | 409.5M | 1.2B | 1.6B | 2.1B | 2.4B | 2.5B | |
| Cost Of Revenue | 2.5B | 3.8B | 4.7B | 7.9B | 9.1B | 9.5B | |
| Income Before Tax | 42.9M | 790.7M | 1.2B | 1.7B | 1.9B | 2.0B | |
| Net Income | 23.3M | 586.2M | 861.5M | 1.2B | 1.4B | 1.5B | |
| Income Tax Expense | 19.6M | 204.5M | 310.3M | 421.5M | 484.7M | 509.0M | |
| Tax Provision | 19.6M | 204.5M | 310.3M | 421.5M | 484.7M | 509.0M | |
| Interest Income | 33.4M | 34.1M | 42.8M | 168.9M | 194.2M | 203.9M | |
| Net Interest Income | (33.4M) | (34.1M) | (42.8M) | (40.6M) | (46.7M) | (49.0M) |
Indraprastha MedicalLimited Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Indraprastha MedicalLimited. It measures of how well Indraprastha is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Indraprastha MedicalLimited brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Indraprastha had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Indraprastha MedicalLimited has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 33.3M | (12.5M) | 15.4M | 9.2M | 10.6M | 11.1M | |
| Change In Cash | 45.9M | 168.2M | 105.2M | 93.4M | 107.4M | 112.8M | |
| Free Cash Flow | 69.4M | 418.1M | 998.9M | 1.3B | 1.5B | 1.6B | |
| Depreciation | 333.2M | 349.4M | 392.7M | 400.8M | 460.9M | 300.3M | |
| Other Non Cash Items | (85.3M) | (162.6M) | (186.4M) | (193.5M) | (174.2M) | (182.9M) | |
| Dividends Paid | 2.5M | 2.6M | 228.4M | (275.4M) | (247.9M) | (235.5M) | |
| Capital Expenditures | 209.6M | 294.8M | 445.8M | 693.9M | 798.0M | 837.9M | |
| Net Income | 42.9M | 790.7M | 1.2B | 1.2B | 1.4B | 1.5B | |
| End Period Cash Flow | 249.2M | 417.4M | 522.6M | 616M | 708.4M | 743.8M | |
| Net Borrowings | (260M) | (228.5M) | (20.9M) | (25.1M) | (28.9M) | (30.3M) | |
| Change To Netincome | 37.3M | (56.4M) | (65.7M) | 41.9M | 37.7M | 39.6M | |
| Investments | (201.6M) | (241M) | (1.1B) | (1.6B) | (1.4B) | (1.4B) |
Indraprastha Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Indraprastha MedicalLimited's current stock value. Our valuation model uses many indicators to compare Indraprastha MedicalLimited value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Indraprastha MedicalLimited competition to find correlations between indicators driving Indraprastha MedicalLimited's intrinsic value. More Info.Indraprastha Medical is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Indraprastha Medical is roughly 2.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indraprastha MedicalLimited's earnings, one of the primary drivers of an investment's value.Indraprastha MedicalLimited Systematic Risk
Indraprastha MedicalLimited's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Indraprastha MedicalLimited volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Indraprastha MedicalLimited correlated with the market. If Beta is less than 0 Indraprastha MedicalLimited generally moves in the opposite direction as compared to the market. If Indraprastha MedicalLimited Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Indraprastha MedicalLimited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Indraprastha MedicalLimited is generally in the same direction as the market. If Beta > 1 Indraprastha MedicalLimited moves generally in the same direction as, but more than the movement of the benchmark.
Indraprastha Medical Total Assets Over Time
Indraprastha MedicalLimited Thematic Clasifications
Indraprastha Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Indraprastha MedicalLimited March 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Indraprastha MedicalLimited help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Indraprastha Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Indraprastha Medical based on widely used predictive technical indicators. In general, we focus on analyzing Indraprastha Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Indraprastha MedicalLimited's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 24.68 | |||
| Value At Risk | (5.91) | |||
| Potential Upside | 5.57 |
Complementary Tools for Indraprastha Stock analysis
When running Indraprastha MedicalLimited's price analysis, check to measure Indraprastha MedicalLimited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indraprastha MedicalLimited is operating at the current time. Most of Indraprastha MedicalLimited's value examination focuses on studying past and present price action to predict the probability of Indraprastha MedicalLimited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indraprastha MedicalLimited's price. Additionally, you may evaluate how the addition of Indraprastha MedicalLimited to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |